Many patients treated with NeuroStar TMS Therapy® experience significant benefits. In open-label clinical trials, after 4 to 6 weeks of treatment1:
1 in 2 patients improved significantly
1 in 3 patients were free of depression symptoms
In a controlled clinical trial comparing depression treatment with an active NeuroStar TMS Therapy system to an inactive device, the average reduction in depression symptom score was1:
22.1% for patients treated with NeuroStar TMS Therapy
9% for patients on inactive treatment
Six clinical studies with 800 patients show that NeuroStar TMS Therapy is an effective treatment approach to achieving remission for patients living with depression. 1,3-5
NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant medication for the treatment of depression. Its effectiveness has also not been established in patients who have failed to receive benefit from two or more prior antidepressant medications at minimal effective dose and duration in the current episode.
Demitrack MA, Thase ME. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharmacol Bull. 2009;42(2):5-38.
O’Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216.
George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67(5):507-516.
Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite naturalistc, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012;29(7):587-596.
Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010;3(4):187-199.
Indication *NeuroStar TMS Therapy® is an FDA-cleared, non-drug treatment for patients with depression who have not benefitted from one prior antidepressant medication. NeuroStar TMS Therapy is available by prescription only. Only a doctor can help decide if NeuroStar TMS Therapy is right for you. Click Here for Full Safety and Prescribing Information